Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Pirarubicina")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 49

  • Page / 2
Export

Selection :

  • and

Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group TrialITO, Akihiro; SHINTAKU, Ichiro; NAMIKI, Shunichi et al.Journal of clinical oncology. 2013, Vol 31, Num 11, pp 1422-1427, issn 0732-183X, 6 p.Article

Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude miceFAVOULET, Patrick; BENOIT, Laurent; OSMAK, Liliana et al.World journal of surgery. 2004, Vol 28, Num 5, pp 451-456, issn 0364-2313, 6 p.Article

Postoperative adjuvant chemotherapy with cisplatin, etoposide, and pirarubicin for endometrial carcinoma patients with lymph node metastasis : A pilot studyUMESAKI, N; TANAKA, T; MIYAMA, M et al.Oncology reports. 2000, Vol 7, Num 5, pp 1083-1086, issn 1021-335XArticle

Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancerCHARRIER, S; CHOLLET, P; BAY, J.-O et al.Bone marrow transplantation (Basingstoke). 2000, Vol 25, Num 7, pp 705-710, issn 0268-3369Article

Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiationTEILLAUD, J. L; GRUEL, N; MONCUIT, J et al.Biomedicine & pharmacotherapy. 1998, Vol 52, Num 6, pp 282-290, issn 0753-3322Article

N,N-bis(Cyclohexanol)amine Aryl Esters : A New Class of Highly Potent Transporter-Dependent Multidrug Resistance InhibitorsMAFLELLI, Cecilia; ALDERIGHI, Daniela; SCAPECCHI, Serena et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 3, pp 807-817, issn 0022-2623, 11 p.Article

Evaluation of the effect of SMA-pirarubicin micelles on colorectal cancer liver metastases and of hyperbaric oxygen in CBA miceDARUWALLA, Jurstine; GREISH, Khaled; NIKFARJAM, Mehrdad et al.Journal of drug targeting. 2007, Vol 15, Num 7-8, pp 487-495, issn 1061-186X, 9 p.Article

Isomeric N,N -bis(cyclohexanol)amine aryl esters : The discovery of a new class of highly potent p-glycoprotein (Pgp)-dependent multidrug resistance (MDR) inhibitorsTEODORI, Elisabetta; MARTELLI, Cecilia; SALERNO, Milena et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 4, pp 599-602, issn 0022-2623, 4 p.Article

Preparation and pharmacokinetics of pirarubicin loaded dehydration-rehydration vesiclesKAWANO, Kumi; TAKAYAMA, Kozo; NAGAI, Tsuneji et al.International journal of pharmaceutics. 2003, Vol 252, Num 1-2, pp 73-79, issn 0378-5173, 7 p.Article

Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublinesMEESUNGNOEN, Jintana; JAY-GERIN, Jean-Paul; MANKHETKORN, Samlee et al.Canadian journal of physiology and pharmacology. 2002, Vol 80, Num 11, pp 1054-1063, issn 0008-4212, 10 p.Article

Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhoodTOYODA, Y; MANABE, A; SATO, T et al.Journal of clinical oncology. 2000, Vol 18, Num 7, pp 1508-1516, issn 0732-183XArticle

Adjuvant chemotherapy including cisplatin in Endometrial carcinomaFUJIMURA, H; KIKKAWA, F; OGUCHI, H et al.Gynecologic and obstetric investigation. 2000, Vol 50, Num 2, pp 127-132, issn 0378-7346Article

Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III : Pathologic correlationTSUBOI, N; OGAWA, Y; INOMATA, T et al.Oncology reports. 1999, Vol 6, Num 4, pp 727-732, issn 1021-335XArticle

High dose chemotherapy for refractory urothelial carcinoma supported by peripheral blood stem cell transplantationNISHIMURA, M; NASU, K; OHTA, H et al.Cancer. 1999, Vol 86, Num 9, pp 1827-1831, issn 0008-543XArticle

Etude des interactions d'anthracyclines avec des monocouches et bicouches lipidiques planes par mesures de pression de surface et diffusion Raman exaltée de surface (SERS) = Study of the interaction of anthracyclines with lipid planar monolayers and bilayers by surface-pressure measurements and surface-enhanced Raman spectroscopyHeywang, Christine; Saint Pierre Chazalet, Christine.1998, 275 p.Thesis

Evidence for reversal of multidrug resistance by quinine in LR73 cells without alteration of nuclear pirarubicin uptake and down-regulation of mdr1 gene expressionBELHOUSSINE, R; MORJANI, H; LAHLIL, R et al.International journal of cancer. 1997, Vol 73, Num 4, pp 600-606, issn 0020-7136Article

Incorporation of exogenous molecules inside mono- and bilayers of phospholipids : Influence of the mode of preparation revealed by SERRS and surface pressure studiesHEYWANG, C; SAINT-PIERRE CHAZALET, M; MASSON, M et al.Langmuir. 1996, Vol 12, Num 26, pp 6459-6467, issn 0743-7463Article

Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphomaHARA, Takeshi; TSURUMI, Hisashi; SAWADA, Michio et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 1, pp 65-70, issn 0171-5216, 6 p.Article

Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-hodgkin's lymphoma: A comparison of doxorubicin and pirarubicin: A randomized phase II studyTSURUMI, Hisashi; YAMADA, Toshiki; OYAMA, Masami et al.Journal of cancer research and clinical oncology. 2004, Vol 130, Num 2, pp 107-113, issn 0171-5216, 7 p.Article

Réponse majeure d'un volumineux carcinome hépatocellulaire à une chimioembolisation par pirarubicine, amiodarone et Lipiodol® = Sustained clinical response of large hepatocellular carcinoma after chemoembolization with pirarubicin, amiodarone and Lipiodol®CERCUEIL, Jean-Pierre; FERRANT, Emmanuelle; ISAMBERT, Nicolas et al.Gastroentérologie clinique et biologique. 2004, Vol 28, Num 12, pp 1281-1283, issn 0399-8320, 3 p.Article

Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patientsOGAWA, Yasuhiro; NISHIOKA, Akihito; NISHIGAWA, Tohru et al.Oncology reports. 2003, Vol 10, Num 4, pp 985-989, issn 1021-335X, 5 p.Article

p53, bcl-2 and thymidine phosphorylase as predictive markers of chemotherapy in patients with advanced and recurrent gastric cancerKIKUYAMA, Shigehiro; INADA, Takao; SHIMIZU, Kazuhiko et al.Anticancer research. 2001, Vol 21, Num 3C, pp 2149-2153, issn 0250-7005Article

The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancerYAMAMOTO, Y; NASU, Y; SAIKA, T et al.BJU international (Papier). 2000, Vol 86, Num 7, pp 802-804, issn 1464-4096Article

Mobilization of peripheral blood progenitor cells after induction chemotherapy (THP-doxorubicin-vinorelbine-cyclophosphamide-fluorouracil) and granulocyte colony-stimulating factor in breast cancerCHARRIER, S; CHASSAGNE, J; CURE, H et al.Bone marrow transplantation (Basingstoke). 1998, Vol 22, Num 9, pp 845-851, issn 0268-3369Article

Pharmacokinetics of intra-arterially administered pirarubicin in plasma and cerebrospinal fluid of patients with gliomaMORIKAWA, N; MORI, T; TAKEYAMAE, M et al.Biological & pharmaceutical bulletin. 1998, Vol 21, Num 3, pp 297-299, issn 0918-6158Article

  • Page / 2